AQP1 and neoplasm: The continuous interaction between tumor and immune cells modulates ERK1/2 in the immune system via specific co-receptors or soluble factors released by the tumor, increasing the ratio between immune-suppressive/pro-tumor and immune-active/anti-tumor cells.